1. Home
  2. ZCMD vs ONVO Comparison

ZCMD vs ONVO Comparison

Compare ZCMD & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZCMD
  • ONVO
  • Stock Information
  • Founded
  • ZCMD 2012
  • ONVO 2007
  • Country
  • ZCMD China
  • ONVO United States
  • Employees
  • ZCMD N/A
  • ONVO N/A
  • Industry
  • ZCMD Other Consumer Services
  • ONVO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ZCMD Real Estate
  • ONVO Health Care
  • Exchange
  • ZCMD Nasdaq
  • ONVO Nasdaq
  • Market Cap
  • ZCMD 6.2M
  • ONVO 6.7M
  • IPO Year
  • ZCMD 2020
  • ONVO N/A
  • Fundamental
  • Price
  • ZCMD $2.00
  • ONVO $0.36
  • Analyst Decision
  • ZCMD
  • ONVO
  • Analyst Count
  • ZCMD 0
  • ONVO 0
  • Target Price
  • ZCMD N/A
  • ONVO N/A
  • AVG Volume (30 Days)
  • ZCMD 26.5K
  • ONVO 274.7K
  • Earning Date
  • ZCMD 01-01-0001
  • ONVO 02-06-2025
  • Dividend Yield
  • ZCMD N/A
  • ONVO N/A
  • EPS Growth
  • ZCMD N/A
  • ONVO N/A
  • EPS
  • ZCMD N/A
  • ONVO N/A
  • Revenue
  • ZCMD $17,406,104.00
  • ONVO $103,000.00
  • Revenue This Year
  • ZCMD N/A
  • ONVO $59.08
  • Revenue Next Year
  • ZCMD N/A
  • ONVO $18.24
  • P/E Ratio
  • ZCMD N/A
  • ONVO N/A
  • Revenue Growth
  • ZCMD 1.01
  • ONVO N/A
  • 52 Week Low
  • ZCMD $1.00
  • ONVO $0.32
  • 52 Week High
  • ZCMD $5.50
  • ONVO $1.74
  • Technical
  • Relative Strength Index (RSI)
  • ZCMD 61.05
  • ONVO 39.56
  • Support Level
  • ZCMD $1.91
  • ONVO $0.34
  • Resistance Level
  • ZCMD $1.47
  • ONVO $0.43
  • Average True Range (ATR)
  • ZCMD 0.27
  • ONVO 0.05
  • MACD
  • ZCMD 0.07
  • ONVO -0.01
  • Stochastic Oscillator
  • ZCMD 61.24
  • ONVO 18.67

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

About ONVO Organovo Holdings Inc.

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

Share on Social Networks: